BioCentury
ARTICLE | Clinical News

Azor/Sevikar olmesartan/amlodipine regulatory update

July 15, 2013 7:00 AM UTC

FDA issued a drug safety communication warning that hypertension drug olmesartan can cause intestinal problems known as sprue-like enteropathy, which includes symptoms such as severe, chronic diarrhea...